Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,018 | 60 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $134.29 | 8 | $0 (2024) |
| Celgene Corporation | $127.17 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $85.33 | 4 | $0 (2024) |
| Daiichi Sankyo Inc. | $82.78 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $69.04 | 4 | $0 (2024) |
| BeiGene USA, Inc. | $65.15 | 3 | $0 (2024) |
| PFIZER INC. | $54.74 | 3 | $0 (2024) |
| Lilly USA, LLC | $54.70 | 3 | $0 (2024) |
| Seagen Inc. | $38.46 | 3 | $0 (2022) |
| Astellas Pharma US Inc | $31.72 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $283.42 | 15 | PFIZER INC. ($54.74) |
| 2023 | $260.57 | 15 | Celgene Corporation ($48.00) |
| 2022 | $451.18 | 29 | Novartis Pharmaceuticals Corporation ($97.91) |
| 2021 | $22.70 | 1 | Merck Sharp & Dohme Corporation ($22.70) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $20.87 | General |
| Category: Oncology | ||||||
| 11/06/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Oncology | ||||||
| 08/20/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/11/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Urology | ||||||
| 06/24/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Oncology | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Oncology | ||||||
| 04/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: ONCOLOGY | ||||||
| 03/26/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: ONCOLOGY | ||||||
| 03/13/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| Category: Hematology | ||||||
| 02/21/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: ONCOLOGY | ||||||
| 01/31/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Oncology | ||||||
| 01/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Oncology | ||||||
| 12/19/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Rare Disease | ||||||
| 12/05/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Oncology | ||||||
| 11/28/2023 | Janssen Biotech, Inc. | TALVEY (Biological) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Oncology | ||||||
| 11/01/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: HORMONE THERAPY | ||||||
| 10/03/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $18.24 | General |
| Category: Oncology | ||||||
| 09/20/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.58 | General |
| Category: Hematology | ||||||
| 08/08/2023 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Oncology | ||||||
| 08/02/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 114 | 199 | $24,421 | $11,248 |
| 2022 | 3 | 139 | 206 | $25,505 | $12,482 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 71 | 154 | $19,387 | $8,959 | 46.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 31 | 33 | $2,926 | $1,363 | 46.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 12 | 12 | $2,108 | $926.50 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 75 | 129 | $16,455 | $8,176 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 43 | 55 | $4,938 | $2,202 | 44.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 21 | 22 | $4,111 | $2,104 | 51.2% |
About Teddi Dowling
Teddi Dowling is a Nurse Practitioner healthcare provider based in Pierre, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2021. The National Provider Identifier (NPI) number assigned to this provider is 1457019283.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Teddi Dowling has received a total of $1,018 in payments from pharmaceutical and medical device companies, with $283.42 received in 2024. These payments were reported across 60 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,018).
As a Medicare-enrolled provider, Dowling has provided services to 253 Medicare beneficiaries, totaling 405 services with total Medicare billing of $23,730. Data is available for 2 years (2022–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Pierre, SD
- Active Since 11/29/2021
- Last Updated 12/07/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1457019283
Products in Payments
- REBLOZYL (Biological) $112.68
- KEYTRUDA (Biological) $85.33
- BRUKINSA (Drug) $65.15
- Enhertu (Drug) $53.42
- ERLEADA (Drug) $47.45
- VERZENIO (Drug) $38.01
- ORGOVYX (Drug) $37.82
- KISQALI (Drug) $33.15
- PADCEV (Biological) $30.24
- SCEMBLIX (Drug) $29.66
- ENHERTU (Drug) $29.36
- MEKINIST (Drug) $27.76
- TUKYSA (Drug) $24.84
- PROMACTA (Drug) $24.69
- NINLARO (Drug) $21.62
- TALVEY (Biological) $21.59
- KRAZATI (Drug) $20.87
- INLYTA (Drug) $19.64
- PIQRAY (Drug) $19.03
- ELREXFIO (Drug) $18.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Pierre
Danielle Etzkorn
Nurse Practitioner — Payments: $2,549
Sarah Speck
Nurse Practitioner — Payments: $133.99
Katherine Turner, Cnp, CNP
Nurse Practitioner — Payments: $122.25
Ms. Tami Hogie-Lorenzen, Cnp, CNP
Nurse Practitioner — Payments: $66.55